Satellos Bioscience Inc. (MSCLF)
OTCMKTS
· Delayed Price · Currency is USD
0.4600
-0.0200 (-4.17%)
May 16, 2025, 2:37 PM EDT
Satellos Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 32.71 | 40.07 | 16.71 | 1.42 | 3.85 | 0.56 | Upgrade
|
Short-Term Investments | 8.48 | 8.48 | 13.27 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 41.19 | 48.55 | 29.98 | 1.42 | 3.85 | 0.56 | Upgrade
|
Cash Growth | - | 61.96% | 2008.62% | -63.07% | 583.57% | 83.00% | Upgrade
|
Other Receivables | 0.34 | 0.44 | 0.44 | 0.19 | 0.42 | 0.32 | Upgrade
|
Receivables | 0.34 | 0.44 | 0.44 | 0.19 | 0.42 | 0.32 | Upgrade
|
Prepaid Expenses | 2.84 | 1.76 | 0.11 | 0.03 | 0.03 | 0 | Upgrade
|
Other Current Assets | - | - | 0 | 0 | - | - | Upgrade
|
Total Current Assets | 44.37 | 50.74 | 30.53 | 1.65 | 4.3 | 0.89 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
Long-Term Investments | - | - | 0.03 | 0.03 | - | - | Upgrade
|
Other Intangible Assets | - | - | 2.97 | 2.89 | 5.64 | - | Upgrade
|
Total Assets | 44.37 | 50.75 | 33.54 | 4.58 | 9.95 | 0.89 | Upgrade
|
Accounts Payable | 2.7 | 2.06 | 0.79 | 1.08 | 0.89 | 0.1 | Upgrade
|
Accrued Expenses | - | 1.52 | 1.96 | 1.01 | 0.77 | 0.07 | Upgrade
|
Total Current Liabilities | 2.7 | 3.58 | 2.74 | 2.09 | 1.66 | 0.17 | Upgrade
|
Long-Term Debt | - | - | - | - | - | 0.86 | Upgrade
|
Total Liabilities | 2.7 | 3.58 | 2.74 | 2.09 | 1.66 | 1.03 | Upgrade
|
Common Stock | 78.13 | 73.48 | 46.88 | 22.32 | 22.38 | 3.42 | Upgrade
|
Additional Paid-In Capital | 8.35 | 7.18 | 6.44 | 2.72 | 0.98 | 0.19 | Upgrade
|
Retained Earnings | -63.24 | -52.54 | -35.97 | -23.36 | -16.03 | -3.76 | Upgrade
|
Comprehensive Income & Other | 18.43 | 19.05 | 13.45 | 0.8 | 0.97 | - | Upgrade
|
Shareholders' Equity | 41.67 | 47.16 | 30.8 | 2.49 | 8.28 | -0.14 | Upgrade
|
Total Liabilities & Equity | 44.37 | 50.75 | 33.54 | 4.58 | 9.95 | 0.89 | Upgrade
|
Total Debt | - | - | - | - | - | 0.86 | Upgrade
|
Net Cash (Debt) | 41.19 | 48.55 | 29.98 | 1.42 | 3.85 | -0.29 | Upgrade
|
Net Cash Growth | - | 61.96% | 2008.62% | -63.07% | - | - | Upgrade
|
Net Cash Per Share | 0.32 | 0.42 | 0.35 | 0.04 | 0.16 | -0.02 | Upgrade
|
Filing Date Shares Outstanding | 165.82 | 165.82 | 112.79 | 41.8 | 33 | 12.09 | Upgrade
|
Total Common Shares Outstanding | 165.82 | 165.82 | 112.79 | 41.8 | 33 | 12.09 | Upgrade
|
Working Capital | 41.67 | 47.16 | 27.79 | -0.44 | 2.64 | 0.71 | Upgrade
|
Book Value Per Share | 0.25 | 0.28 | 0.27 | 0.06 | 0.25 | -0.01 | Upgrade
|
Tangible Book Value | 41.67 | 47.16 | 27.83 | -0.4 | 2.64 | -0.14 | Upgrade
|
Tangible Book Value Per Share | 0.25 | 0.28 | 0.25 | -0.01 | 0.08 | -0.01 | Upgrade
|
Machinery | - | - | - | 0.01 | 0.01 | - | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.